EUROPEAN MARKETS FOR CARDIOVASCULAR DISEASE DIAGNOSTIC IMAGING PRODUCTS

496 Pages | 171 Exhibits | 2009 Analysis | Forecasts Through 2011

OVERVIEW:
In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronary heart disease (which by itself is the most common cause of death in the region). Cardiovascular conditions result in direct and indirect costs that exceed €192 billion annually in the countries that comprise the European Union.

In 2008, nearly 43 million cardiovascular disease-related invasive and noninvasive diagnostic imaging procedures were performed in Europe--which for the purposes of this report consists of the countries of France, Germany, Italy, Spain, and the United Kingdom. These procedures generated approximately $3.0 billion in corresponding diagnostic imaging product revenues, with noninvasive diagnostic imaging systems sales accounting for 49% of the total, imaging contrast agents/radiopharmaceuticals sales for 30%, and transcatheter diagnostic systems sales for 21%.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities in the field of diagnostic imaging for cardiovascular disease applications.

Covered topics in this report include angiography catheters, guidewires, and other devices; cardiovascular disease/disorder statistics for Europe; computed tomography systems; contrast agents for cardiovascular disease-related diagnostic X-ray-based imaging, computed tomography, and diagnostic ultrasound procedures; conventional and advanced electrophysiology catheters; conventional X-ray-based imaging systems; diagnostic ultrasound systems; a discussion of the healthcare markets of France, Germany, Italy, Spain, and the United Kingdom; intravascular ultrasound catheters; magnetic resonance imaging systems; nuclear medicine imaging systems; physiologic intravascular stenosis assessment guidewires; and radiopharmaceuticals for cardiovascular disease-related gamma camera and positron emission tomography procedures.



TABLE OF CONTENTS:
EXECUTIVE SUMMARY 

i.	Noninvasive Diagnostic Imaging Systems Market Segment
	a.	Conventional X-Ray Systems
	b.	Computed Tomography Systems
	c.	Magnetic Resonance Imaging Systems
	d.	Nuclear Medicine Imaging Systems
	e.	Diagnostic Ultrasound Systems
ii.	Invasive Diagnostic Imaging Products Market Segment 
	a.	Angiography Devices 
	b	Diagnostic Electrophysiology Catheters 
	c.	Physiologic Intravascular Stenosis Assessment Guidewires 
	d.	Intravascular Ultrasound Catheters
iii	Imaging Contrast Agents and Radiopharmaceuticals Market Segment
	a.	Contrast Agents for Cardiovascular Disease-Related Diagnostic X-Ray-Based Imaging and Computed Tomography Procedures
	b.	Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging Procedures
	c.	Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound Procedures
iv.	Methodology

Exhibit ES-1: Europe, Cardiovascular Disease-Related Diagnostic Imaging, Combined Procedure Volumes Forecast, 2007-2011
Exhibit ES-2: Europe, Cardiovascular Disease-Related Diagnostic Imaging, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit ES-3: Europe, Diagnostic Imaging Products for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011
Exhibit ES-4: Europe, Diagnostic Imaging Products for Cardiovascular Disease-Related Applications,  Combined Market Forecast, by Country, 2007-2011
Exhibit ES-5: Europe, Noninvasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011
Exhibit ES-6: Europe, Noninvasive Diagnostic Imaging Systems or Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011
Exhibit ES-7: Europe, Conventional X-Ray Imaging Systems  for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit ES-8: Europe, Computed Tomography Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit ES-9: Europe, Magnetic Resonance Imaging Systems  for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit ES-10: Europe, Nuclear Medicine Imaging Systems  for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit ES-11: Europe, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit ES-12: Europe, Invasive Diagnostic Imaging Devices for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011
Exhibit ES-13: Europe, Invasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011
Exhibit ES-14: Europe, Angiography Devices, Combined Market Forecast, 2007-2011
Exhibit ES-15: Europe, Diagnostic Electrophysiology Catheters, Combined Market Forecast, 2007-2011
Exhibit ES-16: Europe, Physiologic Intravascular Stenosis Assessment Guidewires, Combined Market Forecast, 2007-2011
Exhibit ES-17: Europe, Intravascular Ultrasound Catheters, Combined Market Forecast, 2007-2011
Exhibit ES-18: Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Combined Market Forecast, 2007-2011
Exhibit ES-19: Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Market Forecast, by Country, 2007-2011
Exhibit ES-20: Europe, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Combined Market Forecast, 2007-2011
Exhibit ES-21: Europe, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Combined Market Forecast, 2007-2011
Exhibit ES-22: Europe, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Combined Market Forecast, 2007-2011

 1. EUROPEAN HEALTHCARE MARKETS 

1.1 The European Union
	1.1.1 A Common Currency
	1.1.2 Regulatory Policies
	1.1.3 Reimbursement
	1.1.4 Healthcare Spending
1.2 Selected European National Healthcare Profiles
	1.2.1 France
		1.2.1.1 Healthcare Organization and Reform
		1.2.1.2 Hospital Services
		1.2.1.3 Medical Device Reimbursement
	1.2.2 Germany	
		1.2.2.1 Healthcare Organization and Reform
		1.2.2.2 Hospital Services
		1.2.2.3 Medical Device Reimbursement
	1.2.3 Italy
		1.2.3.1 Healthcare Organization and Reform
		1.2.3.2 Hospital Services
		1.2.3.3 Medical Device Reimbursement
	1.2.4 Spain
		1.2.4.1 Healthcare Organization and Reform
		1.2.4.2 Hospital Services
		1.2.4.3 Medical Device Reimbursement
	1.2.5 United Kingdom
		1.2.5.1 Healthcare Organization and Reform
		1.2.5.2 Hospital Services
		1.2.5.3 Medical Device Reimbursement

Exhibit 1-1:	European Union, Medical Devices Risk Classification System
Exhibit 1-2:	European Union Population Statistics Comparison for the Years 1997, 2007, and 2017
Exhibit 1-3:	France, Selected National Healthcare Statistics
Exhibit 1-4:	Germany, Selected National Healthcare Statistics
Exhibit 1-5:	Italy, Selected National Healthcare Statistics
Exhibit 1-6:	Spain, Selected National Healthcare Statistics
Exhibit 1-7:	United Kingdom, Selected National Healthcare Statistics

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS  

2.1 The Heart and Circulatory System
	2.1.1 The Cardiac Conduction System
	2.1.2 The Heart Valves
2.2 Diseases/Disorders Involving the Vasculature
	2.2.1 Coronary Heart Disease
		2.2.1.1 Atherosclerosis
			2.2.1.1.1 Description
			2.2.1.1.2 Statistics
		2.2.1.2 Angina Pectoris
			2.2.1.2.1 Description
			2.2.1.2.2 Statistics
		2.2.1.3 Myocardial Infarction
			2.2.1.3.1 Description
			2.2.1.3.2 Statistics
	2.2.2 Hypertension
		2.2.2.1 Description
			2.2.2.1.1 Systolic and Diastolic Pressures
			2.2.2.1.2 Prehypertension
		2.2.2.2 Statistics
	2.2.3 Aneurysm
		2.2.3.1 Description
		2.2.3.2 Statistics
	2.2.4 Stroke
		2.2.4.1 Description
		2.2.4.2 Statistics
2.3 Diseases/Disorders Involving The Cardiac Conduction System
	2.3.1 Types
		2.3.1.1 Bradycardia
			2.3.1.1.1 Description
		2.3.1.2 Sick Sinus Syndrome
			2.3.1.2.1 Description
		2.3.1.3 Heart Block
			2.3.1.3.1 Description
		2.3.1.4 Atrial Fibrillation
			2.3.1.4.1 Description
		2.3.1.5 Tachycardia
			2.3.1.5.1 Description
		2.3.1.6 Ventricular Fibrillation
			2.3.1.6.1 Description
	2.3.2 Statistics
2.4 Diseases/Disorders Involving the Myocardium
	2.4.1 Heart Defects
		2.4.1.1 Description
		2.4.1.2 Statistics
	2.4.2 Heart Failure
		2.4.2.1 Description
		2.2.4.2 Statistics
	2.4.3 Rheumatic Fever/Rheumatic Heart Disease
		2.4.3.1 Description
		2.4.3.2 Statistics
	2.4.4 Heart Valve Disorders
		2.4.4.1 Types
			2.4.4.1.1 Valvular Stenosis
				2.4.4.1.1.1 Description
			2.4.4.1.2 Valvular Regurgitation
				2.4.4.1.2.1 Description
			2.4.4.1.3 Valve Prolapse
				2.4.4.1.3.1 Description
		2.4.4.2 Statistics

Exhibit 2-1:	Cross-Section Diagram of the Heart
Exhibit 2-2:	Cross-Section Diagram of the Heart Valves
Exhibit 2-3:	Men, Number of Deaths due to Cardiovascular Disease, Selected European Countries
Exhibit 2-4:	Women, Number of Deaths due to Cardiovascular Disease, Selected European Countries
Exhibit 2-5:	Total Cholesterol Levels in Men, Selected European Countries, 2005 and 2010
Exhibit 2-6:	Total Cholesterol Levels in Women, Selected European Countries, 2005 and 2010
Exhibit 2-7:	Europe, Atherosclerosis Prevalence, by Country
Exhibit 2-8:	Standard Angina Pectoris Classification
Exhibit 2-9:	Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group
Exhibit 2-10: Europe, Myocardial Infarction Prevalence, by Country
Exhibit 2-11: Europe, Systolic Blood Pressure Levels, Selected MONICA Project Populations, by Gender Group
Exhibit 2-12: Mean Systolic Blood Pressure Levels in Men, Selected European Countries, 2005 and 2010
Exhibit 2-13: Mean Systolic Blood Pressure Levels in Women, Selected European Countries 2005 and 2010
Exhibit 2-14: Europe, Hypertension Prevalence, by Country
Exhibit 2-15: Europe, Aneurysm Prevalence, by Country
Exhibit 2-16: Europe, Stroke Disability and Mortality, By Selected Country
Exhibit 2-17: Europe, Stroke Prevalence, by Country
Exhibit 2-18: Europe, Cardiac Dysrhythmia Prevalence, by Country
Exhibit 2-19: Congenital Heart Defects, Estimated Number of Simple and Complex Cases in the United Kingdom, 2000 and 2010
Exhibit 2-20: United Kingdom, Heart Failure Prevalence, Selected Study Data
Exhibit 2-21: Europe, Heart Failure Prevalence, by Country
Exhibit 2-22: Rheumatic Heart Disease, Estimated Number of Reported Cases, Selected Countries/Regions
Exhibit 2-23: Rheumatic Heart Disease Mortality, Selected European Countries
Exhibit 2-24: Euro Heart Survey on Valvular Heart Disease Patient Population, Native Heart Valve Disorders, by Type
Exhibit 2-25: Europe, Heart Valve Disorder Prevalence, by Country

3. NONINVASIVE DIAGNOSTIC IMAGING PROCEDURES AND PRODUCTS 

3.1 Conventional X-Ray Imaging
	3.1.1 Procedure Volumes
	3.1.2 Products
	3.1.3 Market Forecast
	3.1.4 Competitors
3.2 Computed Tomography
	3.2.1 Procedure Volumes
	3.2.2 Products
	3.2.3 Market Forecast
	3.2.4 Competitors
3.3 Magnetic Resonance Imaging
	3.3.1 Procedure Volumes
	3.3.2 Products
	3.3.3 Market Forecast
	3.3.4 Competitors
3.4 Nuclear Medicine Imaging
	3.4.1 Procedure Volumes
	3.4.2 Products
	3.4.3 Market Forecast
	3.4.4 Competitors
3.5 Ultrasound Imaging
	3.5.1 Procedure Volumes
	3.5.2 Products
	3.5.3 Market Forecast
	3.5.4 Competitors

Exhibit 3-1: Noninvasive Diagnostic Imaging, Selected Applications
Exhibit 3-2: Europe, Cardiovascular Disease-Related Noninvasive Diagnostic Imaging, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 3-3: Europe, Noninvasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011
Exhibit 3-4: Europe, Noninvasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011
Exhibit 3-5: Europe, Cardiovascular Disease-Related Conventional X-Ray Imaging, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 3-6: 2009, Selected Conventional X-Ray-Based Imaging Systems
Exhibit 3-7: Europe, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit 3-8: France, Conventional X-Ray Imaging Systems or Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-9: Germany, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-10: Italy, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-11: Spain, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-12: United Kingdom, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-13: 2008, Europe, Conventional X-Ray Imaging Systems Market, Share by Supplier
Exhibit 3-14: Europe, Cardiovascular Disease-Related Computed Tomography, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 3-15: 2009, Selected Computed Tomography Systems
Exhibit 3-16: Europe, Computed Tomography Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit 3-17: France, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-18: Germany, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-19: Italy, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-20: Spain, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-21: United Kingdom, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-22: 2008, Europe, Computed Tomography Systems Market, Share by Supplier
Exhibit 3-23: Europe, Cardiovascular Disease-Related Magnetic Resonance Imaging, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 3-24: 2009, Selected Magnetic Resonance Imaging Systems
Exhibit 3-25: Europe, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit 3-26: France, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-27: Germany, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-28: Italy, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-29: Spain, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-30: United Kingdom, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-31: 2008, Europe, Magnetic Resonance Imaging Systems Market, Share by Supplier
Exhibit 3-32: Europe, Cardiovascular Disease-Related Nuclear Medicine Imaging, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 3-33: 2009, Selected Nuclear Medicine Imaging Systems
Exhibit 3-34: Europe, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011
Exhibit 3-35: France, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-36: Germany, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-37: Italy, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-38: Spain, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-39: United Kingdom, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-40: 2008, Europe, Nuclear Medicine Imaging Systems Market, Share by Supplier
Exhibit 3-41: Europe, Cardiovascular Disease-Related Diagnostic Ultrasound, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 3-42: 2009, Selected Diagnostic Ultrasound Systems
Exhibit 3-43: Europe, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Combined Market Forecast,  2007-2011
Exhibit 3-44: France, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-45: Germany, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-46: Italy, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-47: Spain, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications,Market Forecast, 2007-2011
Exhibit 3-48: United Kingdom, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011
Exhibit 3-49: 2008, Europe, Diagnostic Ultrasound Imaging Systems Market, Share by Supplier

4. INVASIVE DIAGNOSTIC IMAGING PROCEDURES AND PRODUCTS 

4.1 Angiography
	4.1.1 Procedures
	4.1.2 Products
	4.1.3 Market Forecast
	4.1.4 Competitors
4.2 Electrophysiology Studies
	4.2.1 Procedures
	4.2.2 Products
	4.2.3 Market Forecast
	4.2.4 Competitors
4.3 Guidewire-Based Physiologic Intravascular Stenosis Assessment
	4.3.1 Procedures
	4.3.2 Products
	4.3.3 Market Forecast
	4.3.4 Competitors
4.4 Intravascular Ultrasound
	4.4.1 Procedures
	4.4.2 Products
	4.4.3 Market Forecast
	4.4.4 Competitors

Exhibit 4-1: Europe, Cardiovascular Disease-Related Invasive Diagnostic Imaging, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 4-2: Europe, Invasive Diagnostic Imaging Devices for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011
Exhibit 4-3: Europe, Invasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011
Exhibit 4-4: Europe, Angiography, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 4-5: 2009, Selected Angiography Catheters
Exhibit 4-6: 2009, Selected Diagnostic Guidewires
Exhibit 4-7: 2009, Selected Introducers/Sheaths
Exhibit 4-8: Europe, Angiography Devices, Combined Market Forecast, 2007-2011
Exhibit 4-9: France, Angiography Devices, Market Forecast, 2007-2011
Exhibit 4-10: Germany, Angiography Devices, Market Forecast, 2007-2011
Exhibit 4-11: Italy, Angiography Devices, Market Forecast, 2007-2011
Exhibit 4-12: Spain, Angiography Devices, Market Forecast, 2007-2011
Exhibit 4-13: United Kingdom, Angiography Devices, Market Forecast, 2007-2011
Exhibit 4-14: 2008, Europe, Angiography Devices Market, Share by Supplier
Exhibit 4-15: Europe, Electrophysiology Studies, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 4-16: 2009, Selected Diagnostic Electrophysiology Catheters
Exhibit 4-17: Europe, Diagnostic Electrophysiology Catheters, Combined Market Forecast, 2007-2011
Exhibit 4-18: France, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011
Exhibit 4-19: Germany, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011
Exhibit 4-20: Italy, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011
Exhibit 4-21: Spain, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011
Exhibit 4-22: United Kingdom, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011
Exhibit 4-23: 2008, Europe, Diagnostic Electrophysiology Catheters Market, Share by Supplier
Exhibit 4-24: Europe, Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 4-25: 2009, Selected Guidewires for Physiologic Intravascular Stenosis Assessment
Exhibit 4-26: Europe, Physiologic Intravascular Stenosis Assessment Guidewires, Combined Market Forecast, 2007-2011
Exhibit 4-27: France, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011
Exhibit 4-28: Germany, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011
Exhibit 4-29: Italy, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011
Exhibit 4-30: Spain, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011
Exhibit 4-31: United Kingdom, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011
Exhibit 4-32: 2008, Europe, Physiologic Intravascular Stenosis Assessment Guidewires Market, Share by Supplier
Exhibit 4-33: Europe, Intravascular Ultrasound, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 4-34: 2009, Selected Intravascular Ultrasound Catheters
Exhibit 4-35: Europe, Intravascular Ultrasound Catheters, Combined Market Forecast, 2007-2011
Exhibit 4-36: France, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011
Exhibit 4-37: Germany, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011
Exhibit 4-38: Italy, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011
Exhibit 4-39: Spain, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011
Exhibit 4-40: United Kingdom, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011
Exhibit 4-41: 2008, Europe, Intravascular Ultrasound Catheters Market, Share by Supplier

5. IMAGING CONTRAST AGENTS AND RADIOPHARMACEUTICALS 

5.1 Contrast Agents for Cardiovascular Disease-Related Diagnostic X-Ray-Based Imaging and Computed Tomography Procedures
	5.1.1 Procedures
	5.1.2 Products
	5.1.3 Market Forecast
	5.1.4 Competitors
5.2 Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging Procedures
	5.2.1 Procedures
	5.2.2 Products
	5.2.3 Market Forecast
	5.2.4 Competitors
5.3 Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound Procedures
	5.3.1 Procedures
	5.3.2 Products
	5.3.3 Market Forecast
	5.3.4 Competitors

Exhibit 5-1: Europe, Cardiovascular Disease-Related Diagnostic Imaging Performed w/Contrast Agents/Radiopharmaceuticals, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 5-2: Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Combined Market Forecast, 2007-2011
Exhibit 5-3: Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Market Forecast, by Country, 2007-2011
Exhibit 5-4: Europe, Cardiovascular Disease-Related Contrast-Enhanced X-Ray-Based Imaging and Computed Tomography, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 5-5: Europe, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Combined Market Forecast, 2007-2011
Exhibit 5-6: France, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011
Exhibit 5-7: Germany, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011
Exhibit 5-8: Italy, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011
Exhibit 5-9: Spain, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011
Exhibit 5-10: United Kingdom, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011
Exhibit 5-11: 2008, Europe, Market for Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Share by Supplier
Exhibit 5-12: Europe, Cardiovascular Disease-Related Gamma Camera Imaging and Positron Emission Tomography Scanning, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 5-13: Europe, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Combined Market Forecast, 2007-2011
Exhibit 5-14: France, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011
Exhibit 5-15: Germany, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011
Exhibit5-16: Italy, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011
Exhibit 5-17: Spain, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011
Exhibit 5-18: United Kingdom, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011
Exhibit 5-19: 2008, Europe, Market for Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Share by Supplier
Exhibit 5-20: Europe, Cardiovascular Disease-Related Contrast-Enhanced Diagnostic Ultrasound, Procedure Volumes Forecast, by Country, 2007-2011
Exhibit 5-21: Europe, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Combined Market Forecast, 2007-2011

Exhibit 5-22: France, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011
Exhibit 5-23: Germany, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011
Exhibit5-24: Italy, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011
Exhibit 5-25: Spain, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011
Exhibit 5-26: United Kingdom, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011
Exhibit 5-27: 2008, Europe, Market for Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Share by Supplier

6. COMPANY PROFILES 

6.1	AngioDynamics, Inc.
6.2	C.R. Bard, Inc.
6.3	Bayer Schering Pharma/Bayer HealthCare/Bayer Group
6.4	Boston Scientific Corporation
6.5	Bracco Imaging/Bracco Group
6.6	Cook Group, Inc.
6.7	GE Healthcare, Inc./General Electric Company
6.8	Guerbet Group
6.9	Hitachi Medical Systems Europe/Hitachi
6.10	Johnson & Johnson
6.11	Lantheus Medical Imaging, Inc./Avista Capital Partners
6.12	Mallinckrodt Pharmaceuticals/Covidien LTD
6.13	Medtronic, Inc.
6.14	Philips Healthcare/Royal Philips Electronics NV
6.15	Siemens Healthcare/Siemens AG
6.16	St. Jude Medical, Inc.
6.17	Terumo Interventional Systems/Terumo Corporation
6.18	Toshiba Medical Systems Europe/Toshiba
6.19	Volcano Corporation


COMPANIES COVERED:

  1. ABX GmbH
  2. Acusphere
  3. Agfa HealthCare/Agfa-Gevaert Group
  4. ALOKA Company
  5. AMICAS
  6. Analogic Corporation
  7. AngioDynamics
  8. Arrow International/Teleflex
  9. Axsun Technologies, Inc./Volcano
  10. Babcock & Wilcox Company/McDermott International
  11. C.R. Bard
  12. Bayer
  13. Biosense Webster
  14. Biotronik GmbH
  15. B-K Medical
  16. Bolton Medical
  17. Boston Scientific Corporation
  18. Bracco Imaging/Bracco Group
  19. B. Braun Melsungen AG
  20. Bruker BioSpin Corporation/Bruker AXS
  21. Cardima
  22. Cardinal Health
  23. Carestream Health
  24. CMT Medical Technologies
  25. Cook Group
  26. Cordis Corporation
  27. CordynaMic/Iberhospitex
  28. Covidien
  29. Digirad Corporation
  30. Eckert & Ziegler Strahlen
  31. eRAD Image Medical
  32. Esaote SPA
  33. EURO-PET Berlin Zyklotron
  34. ev3
  35. FONAR
  36. FUJIFILM
  37. Fukuda Denshi
  38. Gamma Medica-Ideas
  39. GE Healthcare
  40. Hitachi Medical
  41. Hologic
  42. Imaging Dynamics Company
  43. InSitu Technologies
  44. Ion Beam Applications
  45. Johnson & Johnson
  46. Kimal
  47. Lantheus Medical Imaging
  48. Mallinckrodt
  49. McKesson
  50. MDS Nordion
  51. Medison
  52. Medtronic
  53. Merit Medical Systems
  54. PETNET Solutions
  55. Siemens
  56. Philips Healthcare
  57. Positron
  58. Radi Medical Systems
  59. Sectra Imtec
  60. Shimadzu Europa
  61. Siemens
  62. SonoSite
  63. St. Jude Medical
  64. Swissray
  65. Targeson
  66. Terumo
  67. Thales Group
  68. Toshiba Medical
  69. VascoMed/Biotronik
  70. Volcano Corporation
  71. Ziehm Imaging GmbH
  72. ZONARE Medical Systems
Contact Us

Need help finding medtech research? Let us help you!